EPISODE · Jun 5, 2024 · 18 MIN
Overcoming Barriers to Delivering Large Molecules to the Brain
from The Bio Report · host Levine Media Group
One of the challenges of treating neurodegenerative diseases is delivering therapies across the blood-brain barrier. Aliada Therapeutics is developing therapies that use its platform technology that enables the delivery of large molecules, like antibodies, across that barrier. Its lead program is in development to treat Alzheimer’s disease. We spoke to John Dunlop, chief scientific officer of Aliada, about its platform technology, its origins at Johnson & Johnson’s Janssen, and the company’s partnering strategy for leveraging the technology.
What this episode covers
John Dunlop, chief scientific officer of Aliada, discusses its platform technology, its origins at Johnson & Johnson’s Janssen, and the company’s partnering strategy for leveraging the technology.
NOW PLAYING
Overcoming Barriers to Delivering Large Molecules to the Brain
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m